Abstract
We report a patient with the McCune-Albright syndrome and growth hormone excess. Biochemical evaluation demonstrated characteristic changes typical of acromegaly, and an unusual pattern of delayed somatotropin response to hGHRH40, not previously described in this syndrome. Therapeutic trial of low-dose octreotide successfully reversed his growth hormone excess, whereas bromocriptine failed to reduce growth hormone levels. Previous reports of acromegaly and McCune-Albright syndrome are reviewed, and the unique features of this case discussed
Similar content being viewed by others
References
Lee P.A., Van Dop C., Migeon C.J. McCune-Albright Syndrome: Long-term follow-up. JAMA 256: 2980, 1986.
Cuttler L., Jackson J.A., uz-Zafar M.S., Levitsly I.L., Mellinger R.C., Frohman L.A. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J. Clin. Endocrinol. Metab 68: 1148, 1989.
Geffner M.E., Nagel R.A., Dietrich R.B., Kaplan S.A. Treatment of acromegaly with a somatostatin analog in a patient with McCune-Albright syndrome. J. Pediatr. 111: 740, 1987.
Abs R., Beckers A., Van de Vyver F.L., De Schepper A., Stevenaert A., Hennen G. Acromegaly, multinodular goiter and silent polyostotic fibrous dysplasia: A variant of the McCune-Albright syndrome. J. Endocrinol. Invest. 13: 671, 1990.
Hamilton C.R., Maloof F. Unusual types of hyperthyroidism. Medicine 52: 195, 1973.
Frohman L.A., Thominet J.L., Webb C.B., Vance M.L., Uderman H., Rivier J., Vale W., Thorner M.O. Metabolic clearance and plasma disappearance rates of human pancreatic tumor growth hormone releasing factor in man. J. Clin. Invest. 73: 1304, 1984.
Kourides I.A., Weintraub B.D., Levko M.A., Maloof F. Alpha and beta subunits of human thyrotropin: Purification and development of specific radioimmunoassay. Endocrinology 94: 411, 1974.
Steinbach H.L. Russell W. Measurement of the heel-pad as an aid to diagnosis of acromegaly. Radiology 82: 418, 1964.
Kleinberg D.L. Young I.S., Kupperman H.S. The sesamoid index: An aid in the diagnosis of acromegaly. Ann. Intern. Med. 64: 1075, 1966.
Albright F., Butler A.M., Hampton A.O., Smith P. Syndrome characterized by osteitis fibrosa disseminata, areas of pigmentation and endocrine dysfunctional with precocious puberty in females. N. Engl. J. Med. 216: 727, 1937.
MacMahon H.E. Albright’s syndrome — thirty years later (polyostotic fibrous dysplasia). In: Somers S.C. (Ed.) Pathology Annual. Appleton-Century-Croft, New York 1971, p.p. 6-81-147.
Lamberg B.A., Pelkonen R., Aro A., Grahne B. Thyroid function in acromegaly before and after transphenoidal hypophysectomy followed by cryoapplication. Acta Endocrinol. (Copenh.) 82: 254, 1976.
Vance M.L., Borges J.L.C., Kaiser D.L., Evans W.S., Furlanetto R., Thorninet J.L., Frohman L.A., Rogol A.D., MacLeod R.M., Bloom S., Rivier J., Vale W., Thorner M.O. Human pancreatic tumor growth hormone-releasing factor: Dose response relationships in normal man. J. Clin. Endocrinol. Metab. 58: 838, 1984.
Shibasaki T., Hotta M., Masuda A., Imaki T., Obara N., Hizuka N., Takano K. Wakabayashi L., Demura H.L., Ling N., Shizume K. Studies on the response of growth hormone (GH) secretion to GH-releasing hormone, thyrotropin-releasing hormone, gonadotropin-releasing hormone, and somatostatin in acromegaly. J. Clin. Endocinol. Metab. 63: 167, 1986.
Scurry M.T., Bicknell J.M., Fajans S.S. Polyostotic fibrous dysplasia and acromegaly. Arch. Intern. Med. 114: 40, 1964.
Lightner E.S., Penny R., Frasier S.D. Growth hormone excess and sexual precocity in polystotic fibrous dysplasia (McCune-Albright syndrome): Evidence for abnormal hypothalamic function. J. Pediatr. 87: 922, 1975.
Lightner E.S., Penny R., Frasier S.D. Pituitary adenoma in McCune-Albright syndrome: Follow-up information. [Letter] J. Pediatr. 89:159, 1976.
Joishy S.K., Morrow L.B. McCune-Albright syndrome associated with a functioning pituitary chromophobe adenoma. J. Pediatr. 89: 73, 1976.
Powell D.G.B. Polyostotic fibrous dysplasia with acromegaly (Albright’s syndrome): A case report. S. Afr. Med. J. 50: 182, 1976.
Carr D., Mathie I.K., Manners A.R., Colman C. Hyperprolactinemia in a patient with the McCune-Albright syndrome. Br. J. Obstet. Gynecol. 86: 330, 1979.
Albin J., Wu R. Abnormal hypothalamic-pituitary function in polyostotic fibrous dysplasia. Clin. Endocrinol. (Oxf.) 14: 435, 1981.
Lipson A., Hsu T.H. The Albright syndrome associated with acromegaly Report of a case and review of the literature. Johns Hopkins Med. J. 149: 10, 1981.
Polychronakos C., Tsoukas G., Ducharme J.R., Letarte J., Collu R. Gigantism and hyperprolactinemia in polyostotic fibrous dysplasia (McCune-Albright syndrome). J. Endocrinol. Invest. 5: 323, 1982.
Chung K.F., Alaghband-Zadeh J., Guz A. Acromegaly and hyperprolactinemia in McCune-Albright syndrome. Am. J. Dis. Child. 137: 134, 1983.
Hall M.B., Sclar A.G., Gardner D.F. Albright’s syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma and further complicated by osteogenic sarcoma. Oral. Surg. 57: 616, 1984.
Kovacs K., Horvath E., Thorner M.O., Rogol A.D. Mammosomatotroph hyperplasia associated with acromegaly and hyperprolactinemia in a patient with the McCune-Albright syndrome. Virchows Archirv. (Pathol. Anat.) 403: 77, 1984.
Nakagawa H., Nagasaka A., Sugiura T., Nakagawa K., Yabe Y., Nihei N., Hirooka M., Itoh M., Nakai A., Ohyama T., Aono T., Gerich J.E. Gigantism associated with McCune-Albright’s syndrome. Horm. Metab. Res. 17: 522, 1985.
Harris R.I. Polyostotic fibrous dysplasia with acromegaly. Am. J. Med. 78: 539, 1985.
Mauras N., Blizzard R.M. The McCune-Albright syndrome. Acta Endocrinol. (Copehn.) 279 (Suppl.): 207, 1986.
Pacini F., Perri G., Bagnolesi P., Cilotti A., Pinchera A. McCune-Albright syndrome with gigantism and hyperprolactinemia. J. Endocrinol. Invest 10: 417, 1987.
Misaki M., Shima T., Ikoma J., Morioka K., Suzuki S. Acromegaly and hyperthyroidism associated with McCune-Albright syndrome. Horm. Res. 30:26, 1988.
Pun K.K., Chan G., Kung A., Lam K., Chan F.L., Wang C. McCune-Albright syndrome with acromegaly. Horm. Metab. Res. 21: 527, 1989.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sherman, S.I., Ladenson, P.W. Octreotide therapy of growth hormone excess in the McCune-Albright syndrome. J Endocrinol Invest 15, 185–190 (1992). https://doi.org/10.1007/BF03348702
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03348702